BioLattice

BioLattice

Biotechnology Research

Philadelphia, Pennsylvania 301 followers

Revolutionizing Tissue Repair

About us

We are addressing the need for tissue repair solutions, beginning with cornea. One in 70 patients who need cornea tissue obtain it. Globally 2 million per year suffer from corneal blindness while only 200,000 per year receive vision restoration via cornea transplant. There is currently no first line alternative to donor cornea tissue for full thickness cornea transplant material. Our engineered cornea will be a true alternative to donor cornea.

Industry
Biotechnology Research
Company size
1 employee
Headquarters
Philadelphia, Pennsylvania
Type
Privately Held

Locations

  • Primary

    2929 Arch St

    Floor 3

    Philadelphia, Pennsylvania 19104, US

    Get directions

Employees at BioLattice

Updates

Similar pages

Funding

BioLattice 2 total rounds

Last Round

Grant

US$ 10.0K

Investors

Startup302
See more info on crunchbase